查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679208

2030 年聚合物奈米颗粒市场预测：按类型、聚合物类型、应用、最终用户和地区进行的全球分析

Polymeric Nanoparticles Market Forecasts to 2030 - Global Analysis By Type (Nanocapsules and Nanospheres), Polymer Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球聚合物奈米颗粒市值为 7.8425 亿美元，预计到 2030 年将达到 15.7592 亿美元，预测期内的复合年增长率为 12.5%。

聚合物奈米粒子是生物相容性、生物分解性的微小颗粒，尺寸在 10 到 1000 奈米之间，由天然或合成聚合物组成。它们可作为药物、基因和生物分子的载体，增强稳定性、控制释放和标靶递送。其应用涵盖医学、製药和生物技术领域，可提高药物溶解度、生物有效性和治疗效果。

美国国家医学图书馆2023年的研究报告显示，奈米技术有潜力有效治疗50%以上的心血管疾病。

靶向药物传输需求不断增长

聚合物奈米粒子可实现控制和特异性的药物释放，使其成为治疗癌症、心血管和神经系统疾病等慢性疾病的理想选择。由于它们具有防止药物降解和提高生物有效性的能力，因此在製药领域的应用越来越广泛。此外，疾病盛行率的上升和奈米技术研发的不断增加进一步推动了基于聚合物奈米颗粒的药物传输系统的开发和商业化。

潜在的毒性问题

聚合物奈米粒子因其尺寸小、表面反应性强、在组织中生物累积的可能性而具有潜在的毒性问题，从而导致意想不到的健康和环境风险。长时间接触可能会导致细胞损伤、发炎和免疫系统反应。更严格的测试要求和谨慎的消费者看法将进一步推迟商业化，增加成本并降低投资者信心，从而阻碍整体市场成长。

增加奈米医学的投资

政府、製药公司和研究机构的资助促进了用于靶向药物传输、基因治疗和癌症治疗的新型聚合物奈米颗粒製剂的开发。这些投资支持临床试验、监管部门核准和大规模生产，使聚合物奈米颗粒更容易用于医疗应用。因此，扩大奈米医学资金的投入直接推动了聚合物奈米颗粒的需求和应用。

复杂的组合和扩充性的挑战

由于精确的配方要求、复杂的聚合物选择以及对尺寸、稳定性和药物负载效率的控制的需求，聚合物奈米粒子麵临着复杂的合成和可扩展性的挑战。乳液聚合和奈米沉淀等先进技术需要严格的製程控制，这使得大规模生产变得困难且成本高昂。这些挑战阻碍了大规模生产、推高了成本并限制了采用，尤其是在新兴市场。

COVID-19 的影响：

COVID-19 疫情对聚合物奈米颗粒市场产生了重大影响，既有正面影响，也有负面影响。全球供应链中断最初阻碍了生产和原材料的供应。然而，对基于奈米载体的药物输送系统和疫苗开发的需求不断增加，推动了市场的成长。聚合物奈米颗粒在mRNA疫苗和标靶治疗的递送中发挥了重要作用。疫情过后，由于生物医学科学的进步和奈米技术的持续投资，市场继续扩大。

基因治疗领域预计将成为预测期内最大的市场

预计在预测期内，基因治疗领域将占据市场占有率。聚合物奈米粒子能够安全有效地传递遗传物质，在基因治疗中扮演重要角色。这些生物分解性和生物相容性的载体可保护核酸（DNA、RNA）免于降解、促进细胞吸收并实现控制释放。与病毒载体相比，PNP 可以抑制免疫反应并提高基因转移效率。

预计预测期内化妆品和个人护理领域将以最高的复合年增长率成长。

由于产品功效、稳定性和皮肤渗透性的提高，预计化妆品和个人护理领域将在预测期内实现最高成长率。 PNPs 用于护肤、头髮护理、防晒油等，有助于控制释放、维持其有效性并提高生物有效性。 PNP 可保护维生素、抗氧化剂和UV防晒敏感活性成分免于劣化。由于体积小，PNP 可以被皮肤深层吸收，增强其保湿和抗衰老效果。

占比最大的地区：

在预测期内，由于医药、药物输送、化妆品和食品包装的需求不断增加，预计亚太地区将占据最大的市场占有率。中国、印度和日本等国家凭藉着不断扩大的医疗保健基础设施、不断增加的研发投入和技术进步，在市场中占据领先地位。此外，政府对奈米技术研究和永续包装解决方案的支持也促进了市场扩张。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率。这是由于奈米技术的进步、药物传输应用的不断增加以及医疗保健、电子和食品包装行业的需求不断增长。美国以强大的研发投入和医药创新引领市场。政府资助以及生物技术公司和研究机构之间的合作进一步推动了该地区的发展。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球聚合物奈米颗粒市场类型

  • 奈米胶囊
  • 奈米球

6. 全球聚合物奈米颗粒市场（以聚合物类型划分）

  • 天然聚合物
    • 几丁聚醣
    • 纤维素
    • 明胶
    • 海藻酸盐
  • 合成聚合物
    • 聚乳酸（PLA）
    • 聚乳酸-乙醇酸共聚物 (PLGA)
    • 聚己内酯（PCL）
    • 聚乙二醇 (PEG)
    • 聚丙烯酰胺

7. 全球聚合物奈米颗粒市场（依应用）

  • 药物输送
  • 癌症治疗
  • 疫苗递送
  • 诊断和影像
  • 组织工程与再生医学
  • 基因治疗
  • 其他用途

8. 全球聚合物奈米颗粒市场（以最终用户划分）

  • 製药和生物技术
  • 化妆品和个人护理
  • 食品和饮料
  • 农业及农药
  • 其他最终用户

9. 全球聚合物奈米颗粒市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Arkema
  • BASF SE
  • Aphios Corporation
  • Cabot Corporation
  • CD Bioparticles
  • Liquidia Technologies
  • Hybrid Plastics Inc.
  • Nanorh
  • Precision NanoSystems Inc.
  • Sigma-Aldrich
  • Bruker
  • Nanoform
  • Fortis Life Sciences
  • Nanotherapeutics Inc.
  • Spectradyne
  • Revalesio Corporation
  • Cerulean Pharma Inc.
  • Alnylam Pharmaceuticals
Product Code: SMRC28791

According to Stratistics MRC, the Global Polymeric Nanoparticles Market is accounted for $784.25 million in 2024 and is expected to reach $1575.92 million by 2030 growing at a CAGR of 12.5% during the forecast period. Polymeric nanoparticles are tiny, biocompatible, and biodegradable particles ranging from 10 to 1000 nm in size, composed of natural or synthetic polymers. They serve as carriers for drugs, genes, or biomolecules, enhancing stability, controlled release, and targeted delivery. Their applications span medicine, pharmaceuticals, and biotechnology, improving drug solubility, bioavailability, and therapeutic efficiency.

According to a study report by the National Library of Medicines in 2023 revealed that nanotechnology may efficiently treat over 50% of CVDs.

Market Dynamics:

Driver:

Growing demand for targeted drug delivery

Polymeric nanoparticles enable controlled and site-specific drug release, making them ideal for treating chronic diseases like cancer, cardiovascular disorders, and neurological conditions. Their ability to protect drugs from degradation and enhance bioavailability increases their adoption in pharmaceuticals. Additionally, the rising prevalence of diseases and increasing R&D in nanotechnology further drive the development and commercialization of polymeric nanoparticle-based drug delivery systems.

Restraint:

Potential toxicity issues

Polymeric nanoparticles pose potential toxicity issues due to their small size, surface reactivity, and possible bioaccumulation in tissues, leading to unforeseen health and environmental risks. Their prolonged exposure may cause cellular damage, inflammation, or immune system responses. Stricter testing requirements and cautious consumer perception further delay commercialization, increasing costs and reducing investor confidence, thereby hampering overall market growth.

Opportunity:

Increasing investments in nanomedicine

Funding from governments, pharmaceutical companies, and research institutions enables the development of novel polymeric nanoparticle formulations for targeted drug delivery, gene therapy, and cancer treatment. These investments support clinical trials, regulatory approvals, and large-scale production, making polymeric nanoparticles more accessible for medical applications. As a result, expanding nanomedicine funding directly fuels the demand and adoption of polymeric nanoparticles.

Threat:

Complex synthesis & scalability challenges

Polymeric nanoparticles face complex synthesis and scalability challenges due to precise formulation requirements, intricate polymer selection, and the need for controlled size, stability, and drug-loading efficiency. Advanced techniques like emulsion polymerization and nanoprecipitation require strict process control, making large-scale production difficult and expensive. These challenges hinder mass production, increase costs, and limit widespread adoption, especially in developing markets.

Covid-19 Impact:

The covid-19 pandemic significantly impacted the polymeric nanoparticles market, both positively and negatively. Disruptions in the global supply chain initially slowed production and raw material availability. However, increased demand for nanocarrier-based drug delivery systems and vaccine development boosted market growth. Polymeric nanoparticles played a crucial role in mRNA vaccine delivery and targeted therapeutics. Post-pandemic, the market continues to expand, driven by biomedical advancements and sustained investment in nanotechnology.

The gene therapy segment is expected to be the largest during the forecast period

The gene therapy segment is expected to account for the largest market share during the forecast period. Polymeric nanoparticles play a crucial role in gene therapy by enabling safe and efficient delivery of genetic material. These biodegradable and biocompatible carriers protect nucleic acids (DNA, RNA) from degradation, enhance cellular uptake, and enable controlled release. PNPs reduce immune responses and improve gene transfection efficiency compared to viral vectors.

The cosmetics & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetics & personal care segment is predicted to witness the highest growth rate, owing to its enhanced product efficacy, stability, and skin penetration. They are used in skincare, haircare, and sunscreens for controlled ingredient release, prolonged effects, and improved bioavailability. PNPs protect sensitive active ingredients like vitamins, antioxidants, and UV filters from degradation. Their small size enables deeper skin absorption, enhancing hydration and anti-aging benefits.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing demand in pharmaceuticals, drug delivery, cosmetics, and food packaging. Countries like China, India, and Japan are leading the market, driven by expanding healthcare infrastructure, rising R&D investments, and technological advancements. Additionally, government support for nanotechnology research and sustainable packaging solutions contributes to market expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by advancements in nanotechnology, increasing applications in drug delivery, and rising demand in healthcare, electronics, and food packaging industries. The U.S. leads the market with strong R&D investments and pharmaceutical innovations. Government funding and collaborations between biotech firms and research institutions further fuels the region's growth.

Key players in the market

Some of the key players in Polymeric Nanoparticles market include Arkema, BASF SE, Aphios Corporation, Cabot Corporation, CD Bioparticles, Liquidia Technologies, Hybrid Plastics Inc., Nanorh, Precision NanoSystems Inc., Sigma-Aldrich, Bruker, Nanoform, Fortis Life Sciences, Nanotherapeutics Inc., Spectradyne, Revalesio Corporation, Cerulean Pharma Inc. and Alnylam Pharmaceuticals.

Key Developments:

In December 2024, BASF inaugurated its new Catalyst Development and Solids Processing Center in Ludwigshafen, Germany. This state-of-the-art research facility serves as a hub for pilot-scale synthesis of chemical catalysts and the development of new solids processing technologies. The center aims to accelerate the transition from laboratory-scale innovations to production-ready solutions, providing global customers with faster access to advanced technologies.

In May 2024, Arkema introduced the peroxide-cured resin compositions that maintain extended open times at ambient temperatures while achieving rapid cure times when exposed to elevated temperatures. This development signifies Arkema's commitment to advancing materials science, offering solutions that improve both the performance and processing efficiency of resin-based composite materials.

Types Covered:

  • Nanocapsules
  • Nanospheres

Polymer Types Covered:

  • Natural Polymers
  • Synthetic Polymers

Applications Covered:

  • Drug Delivery
  • Cancer Therapy
  • Vaccine Delivery
  • Diagnostics & Imaging
  • Tissue Engineering & Regenerative Medicine
  • Gene Therapy
  • Other Applications

End Users Covered:

  • Pharmaceuticals & Biotechnology
  • Cosmetics & Personal Care
  • Food & Beverages
  • Agriculture & Pesticides
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Polymeric Nanoparticles Market, By Type

  • 5.1 Introduction
  • 5.2 Nanocapsules
  • 5.3 Nanospheres

6 Global Polymeric Nanoparticles Market, By Polymer Type

  • 6.1 Introduction
  • 6.2 Natural Polymers
    • 6.2.1 Chitosan
    • 6.2.2 Cellulose
    • 6.2.3 Gelatin
    • 6.2.4 Alginate
  • 6.3 Synthetic Polymers
    • 6.3.1 Polylactic Acid (PLA)
    • 6.3.2 Poly(lactic-co-glycolic acid) (PLGA)
    • 6.3.3 Polycaprolactone (PCL)
    • 6.3.4 Polyethylene Glycol (PEG)
    • 6.3.5 Polyacrylamide

7 Global Polymeric Nanoparticles Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Delivery
  • 7.3 Cancer Therapy
  • 7.4 Vaccine Delivery
  • 7.5 Diagnostics & Imaging
  • 7.6 Tissue Engineering & Regenerative Medicine
  • 7.7 Gene Therapy
  • 7.8 Other Applications

8 Global Polymeric Nanoparticles Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceuticals & Biotechnology
  • 8.3 Cosmetics & Personal Care
  • 8.4 Food & Beverages
  • 8.5 Agriculture & Pesticides
  • 8.6 Other End Users

9 Global Polymeric Nanoparticles Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.9 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.9 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.9 Middle East & Africa
    • 9.9.1 Saudi Arabia
    • 9.9.2 UAE
    • 9.9.3 Qatar
    • 9.9.4 South Africa
    • 9.9.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Arkema
  • 11.2 BASF SE
  • 11.3 Aphios Corporation
  • 11.4 Cabot Corporation
  • 11.5 CD Bioparticles
  • 11.6 Liquidia Technologies
  • 11.7 Hybrid Plastics Inc.
  • 11.8 Nanorh
  • 11.9 Precision NanoSystems Inc.
  • 11.10 Sigma-Aldrich
  • 11.11 Bruker
  • 11.12 Nanoform
  • 11.13 Fortis Life Sciences
  • 11.14 Nanotherapeutics Inc.
  • 11.15 Spectradyne
  • 11.16 Revalesio Corporation
  • 11.17 Cerulean Pharma Inc.
  • 11.18 Alnylam Pharmaceuticals

List of Tables

  • Table 1 Global Polymeric Nanoparticles Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Polymeric Nanoparticles Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Polymeric Nanoparticles Market Outlook, By Nanocapsules (2022-2030) ($MN)
  • Table 4 Global Polymeric Nanoparticles Market Outlook, By Nanospheres (2022-2030) ($MN)
  • Table 5 Global Polymeric Nanoparticles Market Outlook, By Polymer Type (2022-2030) ($MN)
  • Table 6 Global Polymeric Nanoparticles Market Outlook, By Natural Polymers (2022-2030) ($MN)
  • Table 7 Global Polymeric Nanoparticles Market Outlook, By Chitosan (2022-2030) ($MN)
  • Table 8 Global Polymeric Nanoparticles Market Outlook, By Cellulose (2022-2030) ($MN)
  • Table 9 Global Polymeric Nanoparticles Market Outlook, By Gelatin (2022-2030) ($MN)
  • Table 10 Global Polymeric Nanoparticles Market Outlook, By Alginate (2022-2030) ($MN)
  • Table 11 Global Polymeric Nanoparticles Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 12 Global Polymeric Nanoparticles Market Outlook, By Polylactic Acid (PLA) (2022-2030) ($MN)
  • Table 13 Global Polymeric Nanoparticles Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2022-2030) ($MN)
  • Table 14 Global Polymeric Nanoparticles Market Outlook, By Polycaprolactone (PCL) (2022-2030) ($MN)
  • Table 15 Global Polymeric Nanoparticles Market Outlook, By Polyethylene Glycol (PEG) (2022-2030) ($MN)
  • Table 16 Global Polymeric Nanoparticles Market Outlook, By Polyacrylamide (2022-2030) ($MN)
  • Table 17 Global Polymeric Nanoparticles Market Outlook, By Application (2022-2030) ($MN)
  • Table 18 Global Polymeric Nanoparticles Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 19 Global Polymeric Nanoparticles Market Outlook, By Cancer Therapy (2022-2030) ($MN)
  • Table 20 Global Polymeric Nanoparticles Market Outlook, By Vaccine Delivery (2022-2030) ($MN)
  • Table 21 Global Polymeric Nanoparticles Market Outlook, By Diagnostics & Imaging (2022-2030) ($MN)
  • Table 22 Global Polymeric Nanoparticles Market Outlook, By Tissue Engineering & Regenerative Medicine (2022-2030) ($MN)
  • Table 23 Global Polymeric Nanoparticles Market Outlook, By Gene Therapy (2022-2030) ($MN)
  • Table 24 Global Polymeric Nanoparticles Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 25 Global Polymeric Nanoparticles Market Outlook, By End User (2022-2030) ($MN)
  • Table 26 Global Polymeric Nanoparticles Market Outlook, By Pharmaceuticals & Biotechnology (2022-2030) ($MN)
  • Table 27 Global Polymeric Nanoparticles Market Outlook, By Cosmetics & Personal Care (2022-2030) ($MN)
  • Table 28 Global Polymeric Nanoparticles Market Outlook, By Food & Beverages (2022-2030) ($MN)
  • Table 29 Global Polymeric Nanoparticles Market Outlook, By Agriculture & Pesticides (2022-2030) ($MN)
  • Table 30 Global Polymeric Nanoparticles Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.